Mariner Independent Advisor Network’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.86M | Sell |
156,733
-24,755
| -14% | -$1.2M | 0.29% | 75 |
|
|
2022
Q2 | $9.64M | Buy |
181,488
+9,954
| +6% | +$507K | 0.41% | 55 |
|
|
2022
Q1 | $8.8M | Buy |
171,534
+30,808
| +22% | +$1.6M | 0.34% | 75 |
|
|
2021
Q4 | $8.03M | Sell |
140,726
-17,317
| -11% | -$858K | 0.38% | 61 |
|
|
2021
Q3 | $6.77M | Buy |
158,043
+178
| +0.1% | +$7.89K | 0.33% | 75 |
|
|
2021
Q2 | $6.18M | Buy |
157,865
+3,723
| +2% | +$145K | 0.28% | 87 |
|
|
2021
Q1 | $5.58M | Sell |
154,142
-41,412
| -21% | -$1.47M | 0.29% | 82 |
|
|
2020
Q4 | $7.2M | Buy |
195,554
+34,372
| +21% | +$1.26M | 0.38% | 58 |
|
|
2020
Q3 | $5.61M | Buy |
161,182
+14,659
| +10% | +$514K | 0.47% | 51 |
|
|
2020
Q2 | $4.73M | Sell |
146,523
-6,992
| -5% | -$238K | 0.44% | 59 |
|
|
2020
Q1 | $4.63M | Buy |
153,515
+19,200
| +14% | +$654K | 0.42% | 66 |
|
|
2019
Q4 | $4.99M | Sell |
134,315
-8,091
| -6% | -$288K | 0.36% | 73 |
|
|
2019
Q3 | $4.79M | Buy |
142,406
+10,442
| +8% | +$380K | 0.36% | 72 |
|
|
2019
Q2 | $5.48M | Buy |
131,964
+1,074
| +0.8% | +$42.6K | 0.41% | 57 |
|
|
2019
Q1 | $5.32M | Sell |
130,890
-639
| -0.5% | -$25.6K | 0.45% | 53 |
|
|
2018
Q4 | $5.33M | Buy |
+131,529
| New | +$5.46M | 0.48% | 47 |
|
|
2018
Q3 | – | Sell |
-159,483
| Closed | -$5.49M | – | 270 |
|
|
2018
Q2 | $5.49M | Sell |
159,483
-69,027
| -30% | -$2.36M | 0.97% | 25 |
|
|
2018
Q1 | $7.69M | Buy |
228,510
+131,138
| +135% | +$4.51M | 0.47% | 47 |
|
|
2017
Q4 | $3.35M | Buy |
97,372
+89,005
| +1,064% | +$3.03M | 0.35% | 77 |
|
|
2017
Q3 | $283K | Sell |
8,367
-136,024
| -94% | -$4.37M | 0.05% | 149 |
|
|
2017
Q2 | $4.6M | Buy |
+144,391
| New | +$4.55M | 0.66% | 43 |
|
|
2017
Q1 | – | Sell |
-151,039
| Closed | -$4.65M | – | 323 |
|
|
2016
Q4 | $4.65M | Sell |
151,039
-12,036
| -7% | -$367K | 0.76% | 39 |
|
|
2016
Q3 | $5.24M | Buy |
163,075
+10,142
| +7% | +$339K | 0.75% | 40 |
|
|
2016
Q2 | $5.11M | Buy |
152,933
+77,686
| +103% | +$2.48M | 0.96% | 25 |
|
|
2016
Q1 | $2.12M | Buy |
75,247
+45,634
| +154% | +$1.3M | 0.68% | 47 |
|
|
2015
Q4 | $907K | Buy |
29,613
+5,391
| +22% | +$170K | 0.61% | 42 |
|
|
2015
Q3 | $722K | Buy |
24,222
+5,731
| +31% | +$184K | 0.28% | 87 |
|
|
2015
Q2 | $588K | Buy |
18,491
+4,942
| +36% | +$161K | 0.29% | 71 |
|
|
2015
Q1 | $447K | Sell |
13,549
-3,936
| -23% | -$125K | 0.25% | 70 |
|
|
2014
Q4 | $517K | Buy |
17,485
+9,253
| +112% | +$265K | 0.24% | 77 |
|
|
2014
Q3 | $231K | Sell |
8,232
-220
| -3% | -$6.17K | 0.12% | 116 |
|
|
2014
Q2 | $238K | Buy |
+8,452
| New | +$241K | 0.12% | 116 |
|
Other funds holding PFE
Mariner Independent Advisor Network's PFE Position: Q3 2022 in Review
Mariner Independent Advisor Network reduced its Pfizer (PFE) stake by 14% in Q3 2022, selling an estimated $1.2M and leaving 156,733 shares worth $6.86M. The position accounts for 0.29% of the portfolio, ranked #75.
Mariner Independent Advisor Network first reported a position in PFE in Q2 2014 and has held it in 32 quarters since. The position peaked at $9.64M in Q2 2022. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Mariner Independent Advisor Network held 156,733 shares of Pfizer worth $6.86M as of Q3 2022.
- Mariner Independent Advisor Network sold 24,755 Pfizer shares in Q3 2022, an estimated $1.2M.
- Pfizer made up 0.29% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #75 holding.
- Mariner Independent Advisor Network first reported a position in Pfizer in Q2 2014 and has held it in 32 quarters since.
- Mariner Independent Advisor Network's Pfizer position peaked at $9.64M in Q2 2022.
- 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.